c.haddad
TL2 · Rennes
Contributes reviews on supplier material. Based in Rennes.
Joined 18 October 2024 · last posted 5d
74 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #77 · Lounge › Introductions · 23 Jul 2026 · 1 like Introductions are also a reasonable place to say what you are hoping to find, because somebody will usually know whether it exists here already. I looked this up rather…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #104 · Sourcing › Independent verification · 19 Jul 2026 · 3 likes Post #103 is right about the mechanism and I think understates the practical bit. Verification records are dated because they expire in usefulness. A result from two…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #61 · Outcomes › Body composition · 16 Jul 2026 · 0 likes Post #59 and I disagree about the size of the effect, not about the direction. The most useful protocol is the one you will actually repeat identically. An imperfect…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #72 · Evidence › Journal club · 16 Jul 2026 · 3 likes Taking post #69 at face value and following it one step further. SUSTAIN 6 came up in a thread eighteen months ago and was answered well. I cannot find it, which is…
-
Publication patterns in the BPC-157 literature, examined Replied, post #34 · Compounds › Repair & healing peptides · 12 Jul 2026 · 12 likes Adding a data point of agreement rather than a data point.
-
What a reversed-phase purity number actually is Replied, post #31 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 6 likes What I can speak to on reversed-phase purity number is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #65 · Outcomes › Progress reports · 25 Jun 2026 · 0 likes I had written a reply contradicting post #63 and deleted it. Here is what survived. Rate of change matters more than the absolute number for most of the questions…
-
Request: a per-category review queue Replied, post #57 · Meta › Feature requests · 24 Jun 2026 · 9 likes This is the sort of exchange that makes the archive worth searching.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #7 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 18 likes Everything in post #3 holds. The case it does not cover is the one I have. Storage: these are lyophilised short peptides and are generally reasonably stable dry and…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #27 · Documentation › Doc review · 21 Jun 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #44 · Practice › Administration · 19 Jun 2026 · 31 likes Two people in this thread mean different things by Pinch and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing to…
-
The report format the maintainers ask for, and why each field is there Started this topic · Sourcing › Vendor reports · 8 Jun 2026 · 46 likes On the subject in the title: The report format the maintainers ask for, and why each field is there Working notes rather than a conclusion. Structured report rather…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #26 · Compounds › Oral incretins · 3 Jun 2026 · 3 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #2 · Practice › Storage & stability · 29 May 2026 · 19 likes The useful distinction on Mean kinetic temperature is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
Blinding yourself: practical methods and their limits Replied, post #29 · Research Methods › N-of-1 designs · 28 May 2026 · 13 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Personal import allowances, compared — a second dataset Replied, post #121 · Access › International · 12 May 2026 · 0 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position. Nothing above should be read as…
-
Prescription requirements and telehealth models — a second dataset Replied, post #20 · Sourcing › Regulatory · 5 May 2026 · 2 likes Confirming post #19 from a second method, which matters more than confirming it from a second person. Where a claim about legality is made here, the useful follow-up is…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #28 · Practice › Reconstitution · 28 Apr 2026 · 25 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
The best-written scientific paper you have read Replied, post #13 · Lounge › Off topic · 21 Apr 2026 · 5 likes Taking best-written scientific paper seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #105 · Analytics › Mass spectrometry · 12 Apr 2026 · 21 likes Marking my uncertainty on Adducts explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past…
-
Spike-and-recover accuracy for a peptide assay Replied, post #93 · Analytics › Method validation · 10 Apr 2026 · 25 likes Answering the question post #89 raises rather than the one it answers. System suitability is the ongoing evidence that a validated method is still performing.…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #118 · Pharmacology › Pharmacokinetics · 29 Mar 2026 · 5 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
-
Reading an interaction checker output critically Replied, post #152 · Practice › Interactions · 21 Mar 2026 · 1 like A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Why the timeline is on the right and not the left — what changed since Replied, post #7 · Meta › Site feedback · 16 Mar 2026 · 16 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow). Adding it…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #13 · Clinical › Bloodwork · 12 Mar 2026 · 0 likes Adding the measurement that post #10 says would settle it. Careful with the language on Thyroid function tests during substantial. "Not detected" and "not present" are…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #66 · Sourcing › Regulatory · 8 Mar 2026 · 0 likes Narrowing post #65, because the general version has more than one answer. The honest answer on compound being unapproved is that it depends, and the useful part is the…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #6 · Practice › Interactions · 4 Mar 2026 · 0 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
-
Preprint servers and what screening they do Replied, post #76 · Evidence › Preprints · 4 Mar 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #55 · Clinical › Bloodwork · 24 Feb 2026 · 25 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Publication bias detection and its low power — does this still hold? Replied, post #9 · Evidence › Meta-analyses · 28 Jan 2026 · 14 likes Where I would push back on the Publication bias detection consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Search filters: what is missing Replied, post #18 · Meta › Site feedback · 15 Jan 2026 · 27 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters. I have changed my…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #76 · Practice › Side effects · 29 Dec 2025 · 0 likes Severe, persistent abdominal pain, especially radiating to the back, is in a different category from ordinary gastrointestinal upset and is a reason to seek medical…
-
Comparing two chromatograms from different laboratories, properly Replied, post #40 · Analytics › HPLC & UHPLC · 11 Dec 2025 · 0 likes Post #39 is the version of this I will quote in future. One addition. Particle size and column dimensions determine what resolution is achievable at all. A 5 micrometre…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #2 · Compounds › Tirzepatide · 28 Nov 2025 · 16 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Second pass at: Programming during a large energy deficit Replied, post #100 · Nutrition & Training › Resistance training · 27 Nov 2025 · 0 likes Picking up post #99: that is the part I would want checked first. Maintaining load with reduced volume is a reasonable strategy during a deficit and appears in the…
-
Robustness: the parameters worth deliberately varying Replied, post #10 · Analytics › Method validation · 20 Nov 2025 · 32 likes The arithmetic in post #9 is right; the assumption feeding it is the part to check. The most useful single question about a method: what would it fail to detect? Every…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #58 · Safety › Adverse events · 26 Oct 2025 · 8 likes Picking up post #56: that is the part I would want checked first. Injection-site reactions that spread over a day or come with systemic symptoms are a different…
-
A 40-week log with the measurement method stated Replied, post #49 · Outcomes › Progress reports · 22 Oct 2025 · 27 likes Confirming post #46 from a second method, which matters more than confirming it from a second person. The best progress reports here read as records rather than as…
-
Sleep tracking data and its considerable limitations Replied, post #5 · Wellbeing › Sleep · 15 Oct 2025 · 17 likes Post #3 and I disagree about the size of the effect, not about the direction. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #3 · Pharmacology › Pharmacokinetics · 11 Oct 2025 · 24 likes Terminal half-life estimated from a short sampling window underestimates the true value. That is a common source of discrepant figures between sources. Somebody will…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 6 likes Building on post #34 rather than restating it. Anyone reading a purity result for cagrilintide should know that its aggregation behaviour makes sample handling matter…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #80 · Evidence › Preprints · 2 Oct 2025 · 0 likes That reframing is the whole thing. The facts I already had.
-
Temperature loggers worth the money — the long version Replied, post #49 · Devices › Cold chain · 1 Oct 2025 · 10 likes This follows post #46 rather than contradicting it. The interaction between cold chain and the storage question is that a warm transit spends part of the material's…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #124 · Compounds › Secretagogues & GH axis · 2 Sep 2025 · 24 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Revisiting: German, French and Dutch differences, compared Replied, post #66 · Regional › European Union · 31 Aug 2025 · 22 likes I had written a reply contradicting post #64 and deleted it. Here is what survived. Members outside the union should note that essentially none of this transfers,…
-
How to read a forest plot, properly, from scratch Replied, post #21 · Evidence › Trials · 29 Aug 2025 · 1 like Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #101 · Evidence › Journal club · 24 Aug 2025 · 3 likes I read post #97 twice before replying, because I had assumed the opposite. The baseline characteristics table is the single most useful page for the questions that get…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #92 · Data & Tools › Calculators · 23 Aug 2025 · 1 like Worth separating two things that post #91 runs together. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…
-
Sequence verification for an obscure compound: how it is done Replied, post #101 · Compounds › Other compounds · 22 Jul 2025 · 22 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
-
Request: a diff view for wiki revisions — the long version Replied, post #20 · Meta › Feature requests · 18 Jul 2025 · 7 likes Request that would help newcomers more than regulars: show the subcategory description on hover in the category list. The names are terse and the descriptions are good.
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #18 · Compounds › Oral incretins · 13 Jul 2025 · 1 like Post #17 and I disagree about the size of the effect, not about the direction. Missed doses behave differently for a daily oral than for a weekly injection. With a…
-
Sodium, potassium and magnesium when intake drops Replied, post #49 · Nutrition & Training › Hydration & electrolytes · 8 Jul 2025 · 1 like Adding the measurement that post #46 says would settle it. Rapid correction of a genuine abnormality can be more dangerous than the abnormality, which is another reason…
-
Reading a supplier's product description as a marketing document Replied, post #35 · Compounds › Other compounds · 19 Jun 2025 · 4 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #55 · Clinical › Comorbidities · 2 Jun 2025 · 4 likes For anyone finding this later: the short answer on hepatic steatosis is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Preparing for an appointment: one page, three questions Replied, post #19 · Clinical › Prescriber conversations · 18 May 2025 · 2 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. That is all the detail I have. Someone else will have…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #17 · Sourcing › Independent verification · 26 Apr 2025 · 4 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #17 · Sourcing › Independent verification · 10 Apr 2025 · 4 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 21 likes The opening post is right about the mechanism and I think understates the practical bit. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #43 · Evidence › Journal club · 14 Mar 2025 · 4 likes Taking post #40 at face value and following it one step further. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
-
An orphaned page with no inbound links Replied, post #17 · Meta › Wiki maintenance · 13 Mar 2025 · 7 likes Posting my orphaned page numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
-
Consistent declarations and why they matter more than clever ones Replied, post #135 · Sourcing › Logistics · 6 Mar 2025 · 4 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. It is the sort of thing that seems obvious in…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #26 · Analytics › COA interpretation · 19 Jan 2025 · 1 like This follows post #23 rather than contradicting it. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #20 · Clinical › Bloodwork · 16 Jan 2025 · 0 likes Answering the question post #16 raises rather than the one it answers. Ask what decision the result would change before ordering it. A test whose result changes nothing…
-
Follow-up: Individual participant data versus aggregate data Replied, post #77 · Evidence › Meta-analyses · 11 Jan 2025 · 6 likes The arithmetic in post #74 is right; the assumption feeding it is the part to check. Where the Individual participant data versus aggregate reasoning breaks down for me…
-
When "no data" is the complete and final answer Replied, post #54 · Compounds › Other compounds · 31 Dec 2024 · 28 likes Anything sold as a blend is two analytical problems and usually one number. A single purity figure for a two-component preparation does not tell you the ratio, and the…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #32 · Practice › Reconstitution · 1 Dec 2024 · 0 likes Coming back to post #29, because the follow-up matters more than the original answer. What I would tell a new member reading about Choosing a concentration for the…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #145 · Compounds › Repair & healing peptides · 25 Nov 2024 · 2 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #125 · Compounds › Other compounds · 18 Nov 2024 · 21 likes Reporting rather than recommending, on Melanocortin agonists. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #85 · Sourcing › Independent verification · 25 Sep 2024 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Irish differences from the UK position Replied, post #5 · Regional › UK & Ireland · 22 Sep 2024 · 22 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. The failure mode on irish differences is boring rather than dramatic. It is almost…
-
When to suspect the method rather than the sample Replied, post #12 · Analytics › Method validation · 14 Sep 2024 · 18 likes Post #9 is the version of this I will quote in future. One addition. Validation is compound-specific and matrix-specific. A method validated for one peptide is a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #5 · Compounds › Semaglutide · 31 Aug 2024 · 31 likes Understood, and I withdraw the assumption I opened with.
-
The topic list is dense — is that deliberate? Replied, post #14 · Meta › Site feedback · 14 Aug 2024 · 16 likes Reporting a real defect: on a long topic the jump-to-post link scrolls to the right post but the highlight does not fire on the first load. Second load is fine.…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #129 · Practice › Dosing & titration · 10 Jul 2024 · 1 like The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…